What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
Eur Heart J
.
2024 Jan 1;45(1):70.
doi: 10.1093/eurheartj/ehad728.
Authors
Yuqin Zhao
1
,
Yafang Chen
1
Affiliation
1
Department of Pharmacy, The First People's Hospital of Kunshan, No. 566 Qian Jin East Road, Kunshan 215300, China.
PMID:
37981875
DOI:
10.1093/eurheartj/ehad728
No abstract available
Publication types
Editorial
Comment
MeSH terms
Clopidogrel / therapeutic use
Hemorrhage / chemically induced
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors* / adverse effects
Substances
Platelet Aggregation Inhibitors
Clopidogrel